Delivery Order SPE2DB20D2002-SPE2DB20FL14K
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,091.76, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive assortment of medications,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of medical products and supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,172.70, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide specialty...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, supports the supply of a comprehensive range of medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,394.64, is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This IDC serves as the primary vehicle for the company to deliver pharmaceutical and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,975.48, is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,451.39, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,775.64, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,298.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 that runs through November 2026. The IDC enables the DLA to efficiently procure essential medications,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a broad range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB20FL14KDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $167,741.28, is a delivery order placed under an Indefinite Delivery Contract (IDC) with the DLA that is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $167.7k | 9/1/20 |